Cardiovascular Pharmacology in the Time of COVID-19: A Focus on Angiotensin-Converting Enzyme 2 von Buckley, Leo F., Cheng, Judy W. M., Desai, Akshay

Volltext

Azilsartan Medoxomil: A New Angiotensin Receptor Blocker von Zaiken, Kathy, PharmD, Cheng, Judy W.M., PharmD, MPH, FCCP, BCPS

Volltext

Direct oral anticoagulants in patients with atrial fibrillation and renal impairment, extremes in weight, or advanced age von Buckley, Leo F., Rybak, Eva, Aldemerdash, Ahmed, Cheng, Judy W.M., Fanikos, John

Volltext

Nebivolol: A third-generation β-blocker for hypertension von Cheng, Judy W.M., BS, PharmD, MPH, FCCP, BCPS

Volltext

Comparison of Ambulatory, High-Dose, Intravenous Diuretic Therapy to Standard Hospitalization and Diuretic Therapy for Treatment of Acute Decompensated Heart Failure von Buckley, Leo F., PharmD, Seoane-Vazquez, Enrique, PhD, Cheng, Judy W.M., PharmD MPH, Aldemerdash, Ahmed, PharmD, Cooper, Irene M., RN, Matta, Lina, PharmD MPH, Medina, Danika S., RN, Mehra, Mandeep R., MD, Navarro-Velez, Kristina, RN, Shea, Elaine L., RN, Weintraub, Joanne R., NP, Stevenson, Lynne W., MD, Desai, Akshay S., MD MPH

Volltext

Dabigatran Etexilate: An Oral Direct Thrombin Inhibitor for the Management of Thromboembolic Disorders von Cheng, Judy W.M., BS, PharmD, MPH, FCCP, BCPS, Vu, Huyen

Volltext

Sodium-Glucose Cotransporter 2 Inhibitors Among Heart Failure With Mildly Reduced and Preserved Ejection Fraction von Cheng, Judy W. M., Colucci, Vincent, Kalus, James S., Spinler, Sarah A.

Volltext

Pharmacologic Management of Heart Failure with Preserved Ejection Fraction von HUANG, Dana, CHENG, Judy W. M

Volltext

Aliskiren: Renin inhibitor for hypertension management von Cheng, Judy W.M., BS, PharmD, MPH, FCCP, BCPS

Volltext

Ambrisentan for the management of pulmonary arterial hypertension von Cheng, Judy W.M., BS, PharmD, MPH, FCCP, BCPS

Volltext

Drug Therapy Recommendations from the 2005 ACC/AHA Guidelines for Treatment of Chronic Heart Failure von Howard, Patricia A, Cheng, Judy WM, Crouch, Michael A, Colucci, Vincent J, Kalus, James S, Spinler, Sarah A, Munger, Mark

Volltext

Antiplatelet Therapy After Placement of a Drug-Eluting Stent: A Review of Efficacy and Safety Studies von Mohammad, Rima A., PharmD, BCPS, Goldberg, Tamara, PharmD, BCPS, Dorsch, Michael P., PharmD, MS, BCPS, Cheng, Judy W.M., PharmD, MPH, BCPS, FCCP

Volltext

Oral Terbutaline in Replacement for Intravenous Dopamine in a Patient with End-Stage Heart Failure von Miles, Adele, Shulan, Andrew, Cheng, Judy WM

Volltext

Use of Non-Aspirin Nonsteroidal Antiinflammatory Drugs and the Risk of Cardiovascular Events von Cheng, Judy WM

Volltext

A Review of the Use of Angiotensin Receptor Blockers for the Prevention of Cardiovascular Events in Patients with Essential Hypertension Without Compelling Indications von Zaiken, Kathy, Hudd, Timothy R, Cheng, Judy WM

Volltext

A review of isosorbide dinitrate and hydralazine in the management of heart failure in black patients, with a focus on a new fixed-dose combination von Cheng, Judy W.M.

Volltext

Vernakalant in the Management of Atrial Fibrillation von Cheng, Judy WM

Volltext

Focused Updates: SGLT2 Inhibitors in Patients With Heart Failure and/or Chronic Kidney Disease von Cheng, Judy W. M., Colucci, Vincent, Kalus, James S., Spinler, Sarah A.

Volltext

Reply: Managing Diabetes and Preventing Heart Disease: Have We Found a Safe and Effective Agent? von Cheng, Judy W. M., Colucci, Vincent, Kalus, James S., Spinler, Sarah A.

Volltext

Managing Diabetes and Preventing Heart Disease: Have We Found a Safe and Effective Agent? von Cheng, Judy W. M., Colucci, Vincent J., Kalus, James S., Spinler, Sarah A.

Volltext